News
AstraZeneca PLC (NASDAQ:AZN) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. AstraZeneca PLC (NASDAQ:AZN ...
AstraZeneca (LSE:AZN) recently announced that its investigational antibody, anselamimab, did not achieve statistical ...
3d
Zacks Investment Research on MSNAstrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to KnowIn the latest close session, Astrazeneca (AZN) was down 1.17% at $69.26. This move lagged the S&P 500's daily gain of 0.54%. Elsewhere, the Dow saw an upswing of 0.52%, while the tech-heavy Nasdaq ...
See the latest AstraZeneca PLC ADR stock price (AZN:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
Positive high-level results in trials of its baxdrostat drug to treat hypertension provided AstraZeneca shares with a ...
Despite a Q1 revenue miss due to currency headwinds, core EPS beat expectations for AstraZeneca. Read why AZN stock is a Buy.
5d
Zacks Investment Research on MSNAstraZeneca Meets All Key Goals in Phase III Hypertension StudyAstraZeneca AZN reported positive top-line results from a late-stage study evaluating the safety, tolerability and efficacy ...
Review the current AstraZeneca PLC ADR (AZN:XNAS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if AZN is the best investment for you.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results